C-reactive protein: a physiological activator of interleukin 6 receptor shedding.
about
An aminopeptidase, ARTS-1, is required for interleukin-6 receptor sheddingInduction of proinflammatory cytokines and C-reactive protein in human macrophage cell line U937 exposed to air pollution particulates.Generation of Soluble Interleukin-11 and Interleukin-6 Receptors: A Crucial Function for Proteases during InflammationTherapeutic strategies for the clinical blockade of IL-6/gp130 signalingUsing gene therapy to manipulate the immune system in the fight against B-cell leukemiasPentraxins: structure, function, and role in inflammationAssociation between combined interleukin-6 and C-reactive protein levels and pulmonary function in older women: results from the Women's Health and Aging Studies I and IIThe mediating role of cytokine IL-6 on the relationship of FEV₁ upon 6-minute walk distance in chronic obstructive pulmonary disease.The response of interleukin-6 and soluble interleukin-6 receptor isoforms following intermittent high intensity and continuous moderate intensity cyclingMolecular regulation of hepatocyte generation in adult animalsNovel therapy for Crohn's disease targeting IL-6 signalling.Radiation Inhibits Interleukin-12 Production via Inhibition of C-Rel through the Interleukin-6/ Signal Transducer and Activator of Transcription 3 Signaling Pathway in Dendritic CellsSoluble bio-markers in vascular disease: much more than gauges of disease?The IL6R variation Asp(358)Ala is a potential modifier of lung function in subjects with asthmaMolecular and cellular mechanisms of ectodomain sheddingEvaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer.Shedding of syndecan-1 and -4 ectodomains is regulated by multiple signaling pathways and mediated by a TIMP-3-sensitive metalloproteinase.Interleukin-6 in aging and chronic disease: a magnificent pathwayApoptosis of T cells and the control of inflammatory bowel disease: therapeutic implications.The tumor microenvironment: key to early detection.Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance.Immune opsonins modulate BLyS/BAFF release in a receptor-specific fashion.Soluble interleukin-6 receptor-mediated innate immune response to DNA and RNA viruses.T cells in systemic sclerosis: a reappraisal.IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.Interleukin-6: a new therapeutic target in systemic sclerosis?Biomarkers for differentiation of causes of respiratory distress in dogs and cats: Part 2--Lower airway, thromboembolic, and inflammatory diseases.Management of patients with respiratory infections in primary care: procalcitonin, C-reactive protein or both?The connections among suicidal behavior, lipid profile and low-grade inflammation in patients with major depressive disorder: a specific relationship with the neutrophil-to-lymphocyte ratio.Acrolein stimulates the synthesis of IL-6 and C-reactive protein (CRP) in thrombosis model mice and cultured cells.Prompt tumor formation and maintenance of constitutive NF-kappaB activity of multiple myeloma cells in NOD/SCID/gammacnull mice.Synergistic effects of glycoprotein 130 binding cytokines in combination with interleukin-1 on cartilage collagen breakdown.A multiscale model of interleukin-6-mediated immune regulation in Crohn's disease and its application in drug discovery and development.Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins.A novel mechanism of neutrophil recruitment in a coculture model of the rheumatoid synovium.Interleukin-6 trans-signaling and colonic cancer associated with inflammatory bowel disease.Leptin, soluble interleukin-6 receptor, C-reactive protein and soluble vascular cell adhesion molecule-1 levels in human coronary atherosclerotic plaque.Modeling the Causal Role of DNA Methylation in the Association Between Cigarette Smoking and Inflammation in African Americans: A 2-Step Epigenetic Mendelian Randomization Study.Rheopheresis as a causal therapy option for systemic scleroderma (SSc).Adolescent life-event stress in boys is associated with elevated IL-6 and hepcidin but not hypoferremia.
P2860
Q24301863-2DF56146-A794-41AC-8007-F364F994FA7BQ24810839-8326280C-DD72-486E-A537-4F2149C6598EQ26738992-C2C49ACD-AABC-4A72-A4E6-79B1D8015155Q27002391-B4050B99-916E-4F11-8DA0-1FFF1AAEBF76Q27011297-F0A6562F-906C-4854-A3CF-3C46FE3DC33BQ28676262-9CBCAFDB-DAB4-47C4-928D-B11E334D27F5Q33730864-EA1D1353-5839-4B65-A03C-D000E0126513Q34352974-E74E5077-9B71-429A-874E-1FD2F84B54E7Q34505786-2790DA6D-FF61-496B-B286-BF78AB0EF5C7Q34943112-A365BB63-6AFC-41AD-9124-F33CC5650F54Q35842497-C62FA019-D426-4765-9BC8-773F048B5B05Q35888942-4051E2AF-53B2-482F-B49D-0A9C3C1C1329Q36089375-D384F0CD-8184-496E-99FE-A88B45D4BAAEQ36131162-7F05B41F-1764-4C71-A8BF-28A74E192BB8Q36210626-F6B5588A-C953-43CF-BC00-259CBA2D2AC3Q36230435-62441D3A-9533-4B33-B8E6-D1D2AD32CA3AQ36316404-89A4A7F1-069C-4714-A7C4-CA472BBFDE31Q36518670-930CD8A6-3632-49B5-ADAB-57146634F93EQ36587152-6CDB1D23-503F-4D3E-846E-EE88FB392578Q36627750-F9F5A909-0EC9-4AE0-8865-39D278A8E51BQ36809886-2E1251A5-7016-4FEE-8DA4-6E6427FD31C5Q36934308-DB14FE6E-56E9-4D7B-AAA0-50416DC72A86Q37252579-A8FB7D10-6444-460B-B088-C75266C2E890Q38009282-624FB07D-AFCA-4564-8EA1-F85F6B706A59Q38058509-56A01FC1-415E-46B3-89B0-32E855697634Q38288110-CA437347-5882-4F60-AA1C-F39667149B9AQ38514907-91791609-F2FA-4479-BC02-EB69DE272A48Q38586328-28CDB0ED-FCCF-4AE1-836F-640E76EAB90EQ38643767-508C9CDA-75C8-4E01-AA3F-F407BB8A8661Q39140133-6A143547-A3CD-4F6F-BC8A-30E207011A66Q40537551-EDFA8554-6BD8-43F3-B486-C699F7EDF4E1Q40790873-67DED75E-610F-4C5C-A89C-7702CC1D2ADBQ41906100-5C0531A4-A154-4917-9682-B6D59375DF73Q42487291-0611A1F9-0ACB-427A-891F-2597BA100164Q42766410-1C636623-FC0D-4FDA-933D-E8D89DFBD885Q43965056-D9C92CFD-58FE-4287-8ED3-71E56DD9E5A5Q46951070-8DD0AA65-8D3B-4A0A-BA3D-A079C6E51A64Q47391787-0FC6AC9E-401E-4594-8A7C-6C801C0EDA6CQ47646496-F46DE635-5C16-47C6-B3A0-9E76E4AF0869Q50624093-395E1FEF-25E2-4793-B4C6-387DC19E5BE9
P2860
C-reactive protein: a physiological activator of interleukin 6 receptor shedding.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
C-reactive protein: a physiological activator of interleukin 6 receptor shedding.
@en
C-reactive protein: a physiological activator of interleukin 6 receptor shedding.
@nl
type
label
C-reactive protein: a physiological activator of interleukin 6 receptor shedding.
@en
C-reactive protein: a physiological activator of interleukin 6 receptor shedding.
@nl
prefLabel
C-reactive protein: a physiological activator of interleukin 6 receptor shedding.
@en
C-reactive protein: a physiological activator of interleukin 6 receptor shedding.
@nl
P2093
P2860
P356
P1476
C-reactive protein: a physiological activator of interleukin 6 receptor shedding
@en
P2093
P2860
P304
P356
10.1084/JEM.189.3.599
P407
P577
1999-02-01T00:00:00Z